Syphilis, a bacterial infection caused by Treponema pallidum, is a significant global health concern that has seen a concerning resurgence in recent years. While treatable with antibiotics, the disease's insidious nature and potential for severe, long-term complications, including congenital syphilis, make early and accurate diagnosis critically important. Immunoassay diagnostics have become...

The global syphilis immunoassay diagnostics market is poised for robust growth, projected to expand from US$ 548.5 Mn in 2023 to more than US$ 978.5 Mn by 2034, exhibiting a strong CAGR of 5.5% during the forecast period from 2024 to 2034. A rise in syphilis cases globally, increased awareness around STIs, and advancements in point-of-care testing technologies are driving the demand for...